🇺🇸 FDA
Patent

US 9775891

Methods and compositions for inducing an immune response to EGFRvIII

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 9775891 (Methods and compositions for inducing an immune response to EGFRvIII) held by Providence Health & Services—Oregon expires Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Providence Health & Services—Oregon
Grant date
Tue Oct 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K38/00, A61K39/001104